Adaptimmune Therapeutics
ADAP
#9324
Rank
NZ$0.11 B
Marketcap
$0.46
Share price
-20.31%
Change (1 day)
-79.75%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -$0.89

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.95. In 2022 the company made an earnings per share (EPS) of -$1.82 a decrease over its 2021 EPS that were of -$1.82.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-51.2%
2022-$1.82-0%
2021-$1.826.25%
2020-$1.72-27.27%
2019-$2.3629.41%
2018-$1.8220.09%
2017-$1.52-16.73%
2016-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.85 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.68 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.04 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.51-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA